Ionis Pharmaceuticals, Inc.

This study tested whether a new injectable drug called olezarsen could lower very high triglyceride levels better than a placebo. It involved 617 adults with severely elevated triglycerides who were already on standard cholesterol medications. Participants received either the dru…

This study tested whether a new drug called olezarsen could safely lower high levels of triglycerides, a type of fat in the blood linked to heart disease. About 1,500 adults with high triglycerides and either existing heart disease or a high risk for it received either the drug o…

This study tested whether a new injectable drug called olezarsen could lower very high triglyceride levels in the blood. It involved 446 adults with severely elevated triglycerides who were already on standard medications. Participants received either olezarsen or a placebo injec…

This early-stage study tested the safety of a new Parkinson's drug called BIIB094, which was given as an injection into the spinal fluid. Researchers enrolled 62 adults with Parkinson's disease to check for side effects and measure how the drug moves through the body. The main go…